PLAN FRANCE MÉDECINE
GENOMIQUE 2025

Genomic medicine is profoundly changing patient care. To ensure that everyone has access to new technologies in genomic medicine in an equitable manner throughout the country, France is setting up a plan: the Plan France médecine génomique 2025, the French initiative for genomic medicine. It aims to change methods for diagnosis, prevention and treatment of patients by 2025.
Read more

EVENTS

4 MAJOR ISSUES

Organisation of public health
Genomic medicine is revolutionising the patient care pathway. Routine sequencing of the genome will allow patients more personalised diagnostic and therapeutic management. This will initially concern patients suffering from rare diseases or cancers, then in the future, patients with common diseases.
Scientific and clinical aspects
The aim is to strengthen the chain from exploration of pathologies to therapeutic benefit for the patient.
Technological aspects
New technologies are likely to converge with life sciences and health. The capability to acquire, store, distribute, match and interpret these massive and multiple datasets is at the heart of this convergence.
Economic aspects
Lastly, the challenge is an economic one, both in terms of cost for our health system, and also the development opportunities of a new industrial sector.